Relapse in Multiple Sclerosis
BMJ 350:h1765, Galea, I.,et al, 2015
Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurence
Stroke 42:2509-2514, Broderick, J.,et al, 2011
Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Dietary Treatment in Adults with Refractory Epilepsy
Neurol 83:1978-1985, Klein, P.,et al, 2014
Impact of a Better Adherence to Antihypertensive Agents on Cerebrovascular Disease for Primary Prevention
Stroke 40:213-220, Kettani,F.-Z.,et al, 2009
Compliance With Secondary Prevention of Ischemic Stroke
Stroke 32:1884-1889, Sappok,T.,et al, 2001
Anticoagulant Patient Information Material Is Written at High Readability Levels
Stroke 31:2966-2970, Estrada,C.A.,et al, 2000
Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999
Long-Term Therapeutic Management of Epilepsy
Ann Int Med 120:411-422, French,J., 1994
Status Epilepticus
Am J Med 69:657-665, Aminoff,M.J.,et al, 1980